Prophylactic instillation of hyaluronic acid (HA) and chondroitin sulfate (CS) directly into the bladder can reduce the rate of urinary tract infection (UTI) in women prone to recurrent episodes, ...

In recent years the management of non-muscle-invasive bladder cancer has undergone radical changes. Intravesical Bacillus Calmette-Guérin (BCG) has long been established as the therapeutic standard ...

This page lists all known medications that could potentially lead to 'Instillation site pain' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

ST. PAUL, Minn., Aug. 4, 2022 /PRNewswire/ -- 3M Health Care's Medical Solutions Division has advanced the delivery of 3M™ Veraflo™ Therapy. A new 3M™ Veraflo™ Cleanse Choice Complete™ Dressing Kit ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The multicenter, randomized cross-sectional trial ...

PRINCETON, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative treatments for urothelial and specialty ...

Gemcitabine delivered via intravesical instillation reduced the risk of recurrence in patients with low-grade non-muscle-invasive urothelial cancer, according to results of a randomized phase III ...

Early outcomes with neoadjuvant high-dose intensity methotrexate, vinblastine, doxorubicin, and cisplatin (HD-MVAC) or gemcitabine and cisplatin (GC) in muscle-invasive urothelial carcinoma of the ...

A randomized, prospective, phase II study to determine the efficacy of BCG given in combination with panvac versus BCG alone in adults with high grade non-muscle invasive bladder cancer who failed at ...

Intravesical therapy involving bacillus Calmette–Guérin (BCG) is standard of care for high-grade, noninvasive urothelial carcinoma, with reported cure rates higher than 70%. Systemic infection occurs ...